nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—TLR4—ulcerative colitis	0.0155	0.534	CrCbGaD
Nalbuphine—Hydromorphone—PTGS1—ulcerative colitis	0.00377	0.13	CrCbGaD
Nalbuphine—Naltrexone—ABCB1—ulcerative colitis	0.00253	0.0873	CrCbGaD
Nalbuphine—Naloxone—ALB—ulcerative colitis	0.00193	0.0667	CrCbGaD
Nalbuphine—Cardiac arrest—Prednisone—ulcerative colitis	0.0019	0.00244	CcSEcCtD
Nalbuphine—Dry mouth—Mesalazine—ulcerative colitis	0.00189	0.00244	CcSEcCtD
Nalbuphine—Bradycardia—Hydrocortisone—ulcerative colitis	0.00189	0.00243	CcSEcCtD
Nalbuphine—Feeling abnormal—Budesonide—ulcerative colitis	0.00188	0.00242	CcSEcCtD
Nalbuphine—Confusional state—Mesalazine—ulcerative colitis	0.00187	0.00241	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Budesonide—ulcerative colitis	0.00187	0.0024	CcSEcCtD
Nalbuphine—Buprenorphine—ABCB1—ulcerative colitis	0.00186	0.0641	CrCbGaD
Nalbuphine—Oedema—Mesalazine—ulcerative colitis	0.00186	0.00239	CcSEcCtD
Nalbuphine—Hallucination—Hydrocortisone—ulcerative colitis	0.00185	0.00238	CcSEcCtD
Nalbuphine—Naloxone—ABCB1—ulcerative colitis	0.00184	0.0637	CrCbGaD
Nalbuphine—Shock—Mesalazine—ulcerative colitis	0.00183	0.00235	CcSEcCtD
Nalbuphine—Urticaria—Budesonide—ulcerative colitis	0.00181	0.00233	CcSEcCtD
Nalbuphine—Tachycardia—Mesalazine—ulcerative colitis	0.00181	0.00233	CcSEcCtD
Nalbuphine—Abdominal pain—Budesonide—ulcerative colitis	0.0018	0.00232	CcSEcCtD
Nalbuphine—Body temperature increased—Budesonide—ulcerative colitis	0.0018	0.00232	CcSEcCtD
Nalbuphine—Hyperhidrosis—Mesalazine—ulcerative colitis	0.00179	0.00231	CcSEcCtD
Nalbuphine—Bradycardia—Triamcinolone—ulcerative colitis	0.00178	0.00229	CcSEcCtD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00178	0.00918	CbGpPWpGaD
Nalbuphine—Bradycardia—Methylprednisolone—ulcerative colitis	0.00178	0.00229	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00175	0.00903	CbGpPWpGaD
Nalbuphine—Hallucination—Methylprednisolone—ulcerative colitis	0.00174	0.00223	CcSEcCtD
Nalbuphine—Hypotension—Mesalazine—ulcerative colitis	0.00173	0.00223	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—RIPK2—ulcerative colitis	0.00173	0.00894	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.00168	0.0087	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00168	0.00869	CbGpPWpGaD
Nalbuphine—Sweating increased—Prednisone—ulcerative colitis	0.00168	0.00216	CcSEcCtD
Nalbuphine—Hypersensitivity—Budesonide—ulcerative colitis	0.00168	0.00216	CcSEcCtD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.00168	0.00868	CbGpPWpGaD
Nalbuphine—Feeling abnormal—Azathioprine—ulcerative colitis	0.00168	0.00216	CcSEcCtD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00167	0.00863	CbGpPWpGaD
Nalbuphine—Paraesthesia—Mesalazine—ulcerative colitis	0.00167	0.00214	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.00167	0.00214	CcSEcCtD
Nalbuphine—Erythema—Prednisolone—ulcerative colitis	0.00166	0.00213	CcSEcCtD
Nalbuphine—Dyspnoea—Mesalazine—ulcerative colitis	0.00165	0.00213	CcSEcCtD
Nalbuphine—Somnolence—Mesalazine—ulcerative colitis	0.00165	0.00212	CcSEcCtD
Nalbuphine—Asthenia—Budesonide—ulcerative colitis	0.00164	0.00211	CcSEcCtD
Nalbuphine—Dyspepsia—Mesalazine—ulcerative colitis	0.00163	0.0021	CcSEcCtD
Nalbuphine—Erythema—Hydrocortisone—ulcerative colitis	0.00162	0.00208	CcSEcCtD
Nalbuphine—Bradycardia—Betamethasone—ulcerative colitis	0.00162	0.00208	CcSEcCtD
Nalbuphine—Bradycardia—Dexamethasone—ulcerative colitis	0.00162	0.00208	CcSEcCtD
Nalbuphine—Pruritus—Budesonide—ulcerative colitis	0.00161	0.00208	CcSEcCtD
Nalbuphine—Abdominal pain—Azathioprine—ulcerative colitis	0.00161	0.00207	CcSEcCtD
Nalbuphine—Body temperature increased—Azathioprine—ulcerative colitis	0.00161	0.00207	CcSEcCtD
Nalbuphine—Hallucination—Dexamethasone—ulcerative colitis	0.00158	0.00203	CcSEcCtD
Nalbuphine—Hallucination—Betamethasone—ulcerative colitis	0.00158	0.00203	CcSEcCtD
Nalbuphine—Vision blurred—Prednisolone—ulcerative colitis	0.00156	0.00201	CcSEcCtD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00156	0.00806	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00156	0.00805	CbGpPWpGaD
Nalbuphine—Morphine—ABCB1—ulcerative colitis	0.00156	0.0538	CrCbGaD
Nalbuphine—Depression—Prednisone—ulcerative colitis	0.00154	0.00198	CcSEcCtD
Nalbuphine—Feeling abnormal—Mesalazine—ulcerative colitis	0.00153	0.00197	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00152	0.00787	CbGpPWpGaD
Nalbuphine—Erythema—Triamcinolone—ulcerative colitis	0.00152	0.00196	CcSEcCtD
Nalbuphine—Erythema—Methylprednisolone—ulcerative colitis	0.00152	0.00195	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00152	0.00195	CcSEcCtD
Nalbuphine—Dizziness—Budesonide—ulcerative colitis	0.00151	0.00194	CcSEcCtD
Nalbuphine—Hypersensitivity—Azathioprine—ulcerative colitis	0.0015	0.00193	CcSEcCtD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.0015	0.00775	CbGpPWpGaD
Nalbuphine—Dysgeusia—Triamcinolone—ulcerative colitis	0.00149	0.00192	CcSEcCtD
Nalbuphine—Vertigo—Prednisolone—ulcerative colitis	0.00149	0.00191	CcSEcCtD
Nalbuphine—Syncope—Prednisolone—ulcerative colitis	0.00149	0.00191	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00148	0.00763	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00148	0.00762	CbGpPWpGaD
Nalbuphine—Urticaria—Mesalazine—ulcerative colitis	0.00147	0.0019	CcSEcCtD
Nalbuphine—Body temperature increased—Mesalazine—ulcerative colitis	0.00147	0.00189	CcSEcCtD
Nalbuphine—Abdominal pain—Mesalazine—ulcerative colitis	0.00147	0.00189	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00147	0.00757	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Prednisolone—ulcerative colitis	0.00146	0.00187	CcSEcCtD
Nalbuphine—Vertigo—Hydrocortisone—ulcerative colitis	0.00145	0.00187	CcSEcCtD
Nalbuphine—Vomiting—Budesonide—ulcerative colitis	0.00145	0.00187	CcSEcCtD
Nalbuphine—Syncope—Hydrocortisone—ulcerative colitis	0.00145	0.00187	CcSEcCtD
Nalbuphine—Rash—Budesonide—ulcerative colitis	0.00144	0.00185	CcSEcCtD
Nalbuphine—Dermatitis—Budesonide—ulcerative colitis	0.00144	0.00185	CcSEcCtD
Nalbuphine—Convulsion—Prednisolone—ulcerative colitis	0.00143	0.00185	CcSEcCtD
Nalbuphine—Headache—Budesonide—ulcerative colitis	0.00143	0.00184	CcSEcCtD
Nalbuphine—Hypertension—Prednisolone—ulcerative colitis	0.00143	0.00184	CcSEcCtD
Nalbuphine—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.00142	0.00183	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.00142	0.00734	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00141	0.00728	CbGpPWpGaD
Nalbuphine—Bradycardia—Prednisone—ulcerative colitis	0.00141	0.00181	CcSEcCtD
Nalbuphine—Convulsion—Hydrocortisone—ulcerative colitis	0.0014	0.0018	CcSEcCtD
Nalbuphine—Hypertension—Hydrocortisone—ulcerative colitis	0.0014	0.0018	CcSEcCtD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00139	0.00719	CbGpPWpGaD
Nalbuphine—OPRM1—Opioid Signalling—ADCY5—ulcerative colitis	0.00139	0.00717	CbGpPWpGaD
Nalbuphine—Erythema—Betamethasone—ulcerative colitis	0.00138	0.00178	CcSEcCtD
Nalbuphine—Erythema—Dexamethasone—ulcerative colitis	0.00138	0.00178	CcSEcCtD
Nalbuphine—Hallucination—Prednisone—ulcerative colitis	0.00138	0.00177	CcSEcCtD
Nalbuphine—Anxiety—Hydrocortisone—ulcerative colitis	0.00137	0.00177	CcSEcCtD
Nalbuphine—Vertigo—Triamcinolone—ulcerative colitis	0.00137	0.00176	CcSEcCtD
Nalbuphine—Hypersensitivity—Mesalazine—ulcerative colitis	0.00137	0.00176	CcSEcCtD
Nalbuphine—Syncope—Triamcinolone—ulcerative colitis	0.00137	0.00176	CcSEcCtD
Nalbuphine—Vertigo—Methylprednisolone—ulcerative colitis	0.00137	0.00176	CcSEcCtD
Nalbuphine—Syncope—Methylprednisolone—ulcerative colitis	0.00136	0.00175	CcSEcCtD
Nalbuphine—Nausea—Budesonide—ulcerative colitis	0.00136	0.00174	CcSEcCtD
Nalbuphine—Oedema—Prednisolone—ulcerative colitis	0.00135	0.00174	CcSEcCtD
Nalbuphine—Dizziness—Azathioprine—ulcerative colitis	0.00135	0.00173	CcSEcCtD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00135	0.00696	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Triamcinolone—ulcerative colitis	0.00134	0.00172	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00134	0.00691	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00134	0.0069	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.00134	0.00172	CcSEcCtD
Nalbuphine—Asthenia—Mesalazine—ulcerative colitis	0.00133	0.00171	CcSEcCtD
Nalbuphine—Shock—Prednisolone—ulcerative colitis	0.00133	0.00171	CcSEcCtD
Nalbuphine—Oedema—Hydrocortisone—ulcerative colitis	0.00132	0.0017	CcSEcCtD
Nalbuphine—Convulsion—Triamcinolone—ulcerative colitis	0.00132	0.0017	CcSEcCtD
Nalbuphine—Tachycardia—Prednisolone—ulcerative colitis	0.00132	0.0017	CcSEcCtD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00132	0.00681	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.00132	0.0068	CbGpPWpGaD
Nalbuphine—Convulsion—Methylprednisolone—ulcerative colitis	0.00132	0.00169	CcSEcCtD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00132	0.00679	CbGpPWpGaD
Nalbuphine—Hypertension—Triamcinolone—ulcerative colitis	0.00131	0.00169	CcSEcCtD
Nalbuphine—Pruritus—Mesalazine—ulcerative colitis	0.00131	0.00169	CcSEcCtD
Nalbuphine—Hypertension—Methylprednisolone—ulcerative colitis	0.00131	0.00169	CcSEcCtD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00131	0.00676	CbGpPWpGaD
Nalbuphine—Hyperhidrosis—Prednisolone—ulcerative colitis	0.00131	0.00168	CcSEcCtD
Nalbuphine—Shock—Hydrocortisone—ulcerative colitis	0.0013	0.00167	CcSEcCtD
Nalbuphine—Vomiting—Azathioprine—ulcerative colitis	0.0013	0.00167	CcSEcCtD
Nalbuphine—Anxiety—Methylprednisolone—ulcerative colitis	0.00129	0.00166	CcSEcCtD
Nalbuphine—Tachycardia—Hydrocortisone—ulcerative colitis	0.00129	0.00166	CcSEcCtD
Nalbuphine—Rash—Azathioprine—ulcerative colitis	0.00128	0.00165	CcSEcCtD
Nalbuphine—Dermatitis—Azathioprine—ulcerative colitis	0.00128	0.00165	CcSEcCtD
Nalbuphine—Flushing—Prednisone—ulcerative colitis	0.00128	0.00165	CcSEcCtD
Nalbuphine—Headache—Azathioprine—ulcerative colitis	0.00128	0.00164	CcSEcCtD
Nalbuphine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00128	0.00164	CcSEcCtD
Nalbuphine—Dry mouth—Triamcinolone—ulcerative colitis	0.00127	0.00163	CcSEcCtD
Nalbuphine—Confusional state—Methylprednisolone—ulcerative colitis	0.00125	0.00161	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00125	0.00644	CbGpPWpGaD
Nalbuphine—Oedema—Triamcinolone—ulcerative colitis	0.00124	0.0016	CcSEcCtD
Nalbuphine—Vertigo—Dexamethasone—ulcerative colitis	0.00124	0.0016	CcSEcCtD
Nalbuphine—Vertigo—Betamethasone—ulcerative colitis	0.00124	0.0016	CcSEcCtD
Nalbuphine—Syncope—Dexamethasone—ulcerative colitis	0.00124	0.00159	CcSEcCtD
Nalbuphine—Syncope—Betamethasone—ulcerative colitis	0.00124	0.00159	CcSEcCtD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00124	0.0064	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00124	0.00639	CbGpPWpGaD
Nalbuphine—Hypotension—Hydrocortisone—ulcerative colitis	0.00123	0.00159	CcSEcCtD
Nalbuphine—Dizziness—Mesalazine—ulcerative colitis	0.00123	0.00158	CcSEcCtD
Nalbuphine—Shock—Triamcinolone—ulcerative colitis	0.00122	0.00157	CcSEcCtD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00122	0.0063	CbGpPWpGaD
Nalbuphine—Shock—Methylprednisolone—ulcerative colitis	0.00122	0.00157	CcSEcCtD
Nalbuphine—Loss of consciousness—Betamethasone—ulcerative colitis	0.00121	0.00156	CcSEcCtD
Nalbuphine—Loss of consciousness—Dexamethasone—ulcerative colitis	0.00121	0.00156	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisolone—ulcerative colitis	0.00121	0.00156	CcSEcCtD
Nalbuphine—Tachycardia—Triamcinolone—ulcerative colitis	0.00121	0.00156	CcSEcCtD
Nalbuphine—Nausea—Azathioprine—ulcerative colitis	0.00121	0.00156	CcSEcCtD
Nalbuphine—Tachycardia—Methylprednisolone—ulcerative colitis	0.00121	0.00156	CcSEcCtD
Nalbuphine—Erythema—Prednisone—ulcerative colitis	0.0012	0.00155	CcSEcCtD
Nalbuphine—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.0012	0.00155	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.0012	0.00154	CcSEcCtD
Nalbuphine—Convulsion—Dexamethasone—ulcerative colitis	0.0012	0.00154	CcSEcCtD
Nalbuphine—Convulsion—Betamethasone—ulcerative colitis	0.0012	0.00154	CcSEcCtD
Nalbuphine—Hypertension—Betamethasone—ulcerative colitis	0.00119	0.00153	CcSEcCtD
Nalbuphine—Hypertension—Dexamethasone—ulcerative colitis	0.00119	0.00153	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00119	0.00616	CbGpPWpGaD
Nalbuphine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.00119	0.00152	CcSEcCtD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00118	0.0061	CbGpPWpGaD
Nalbuphine—Vomiting—Mesalazine—ulcerative colitis	0.00118	0.00152	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00117	0.00606	CbGpPWpGaD
Nalbuphine—Anxiety—Betamethasone—ulcerative colitis	0.00117	0.00151	CcSEcCtD
Nalbuphine—Anxiety—Dexamethasone—ulcerative colitis	0.00117	0.00151	CcSEcCtD
Nalbuphine—Rash—Mesalazine—ulcerative colitis	0.00117	0.00151	CcSEcCtD
Nalbuphine—Dermatitis—Mesalazine—ulcerative colitis	0.00117	0.0015	CcSEcCtD
Nalbuphine—Headache—Mesalazine—ulcerative colitis	0.00116	0.0015	CcSEcCtD
Nalbuphine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00116	0.00149	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00116	0.00599	CbGpPWpGaD
Nalbuphine—Hypotension—Methylprednisolone—ulcerative colitis	0.00116	0.00149	CcSEcCtD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00115	0.00595	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00115	0.00593	CbGpPWpGaD
Nalbuphine—Vision blurred—Prednisone—ulcerative colitis	0.00113	0.00146	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00113	0.00583	CbGpPWpGaD
Nalbuphine—Oedema—Betamethasone—ulcerative colitis	0.00113	0.00145	CcSEcCtD
Nalbuphine—Oedema—Dexamethasone—ulcerative colitis	0.00113	0.00145	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00112	0.00579	CbGpPWpGaD
Nalbuphine—Paraesthesia—Triamcinolone—ulcerative colitis	0.00112	0.00144	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisolone—ulcerative colitis	0.00111	0.00143	CcSEcCtD
Nalbuphine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.00111	0.00143	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00111	0.00574	CbGpPWpGaD
Nalbuphine—Shock—Dexamethasone—ulcerative colitis	0.00111	0.00143	CcSEcCtD
Nalbuphine—Shock—Betamethasone—ulcerative colitis	0.00111	0.00143	CcSEcCtD
Nalbuphine—Dyspnoea—Triamcinolone—ulcerative colitis	0.00111	0.00143	CcSEcCtD
Nalbuphine—Agitation—Prednisone—ulcerative colitis	0.00111	0.00142	CcSEcCtD
Nalbuphine—Nausea—Mesalazine—ulcerative colitis	0.0011	0.00142	CcSEcCtD
Nalbuphine—Tachycardia—Betamethasone—ulcerative colitis	0.0011	0.00142	CcSEcCtD
Nalbuphine—Tachycardia—Dexamethasone—ulcerative colitis	0.0011	0.00142	CcSEcCtD
Nalbuphine—Dyspepsia—Triamcinolone—ulcerative colitis	0.00109	0.00141	CcSEcCtD
Nalbuphine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00109	0.0014	CcSEcCtD
Nalbuphine—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.00109	0.0014	CcSEcCtD
Nalbuphine—Hyperhidrosis—Betamethasone—ulcerative colitis	0.00109	0.0014	CcSEcCtD
Nalbuphine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.00109	0.0014	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—ulcerative colitis	0.00108	0.00139	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00108	0.00139	CcSEcCtD
Nalbuphine—Syncope—Prednisone—ulcerative colitis	0.00108	0.00139	CcSEcCtD
Nalbuphine—Urticaria—Prednisolone—ulcerative colitis	0.00107	0.00138	CcSEcCtD
Nalbuphine—OPRM1—IL4-mediated signaling events—JAK2—ulcerative colitis	0.00107	0.00553	CbGpPWpGaD
Nalbuphine—Loss of consciousness—Prednisone—ulcerative colitis	0.00106	0.00136	CcSEcCtD
Nalbuphine—Hypotension—Dexamethasone—ulcerative colitis	0.00105	0.00136	CcSEcCtD
Nalbuphine—Hypotension—Betamethasone—ulcerative colitis	0.00105	0.00136	CcSEcCtD
Nalbuphine—Urticaria—Hydrocortisone—ulcerative colitis	0.00105	0.00135	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00105	0.0054	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00104	0.0054	CbGpPWpGaD
Nalbuphine—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00104	0.00134	CcSEcCtD
Nalbuphine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00104	0.00134	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—ulcerative colitis	0.00104	0.00134	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—ulcerative colitis	0.00104	0.00134	CcSEcCtD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00103	0.00533	CbGpPWpGaD
Nalbuphine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.00102	0.00132	CcSEcCtD
Nalbuphine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.00102	0.00131	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—ulcerative colitis	0.00102	0.00131	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CCL20—ulcerative colitis	0.00102	0.00526	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00102	0.00526	CbGpPWpGaD
Nalbuphine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.00101	0.0013	CcSEcCtD
Nalbuphine—Paraesthesia—Dexamethasone—ulcerative colitis	0.00101	0.0013	CcSEcCtD
Nalbuphine—Paraesthesia—Betamethasone—ulcerative colitis	0.00101	0.0013	CcSEcCtD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00101	0.00522	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000998	0.00516	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000996	0.00128	CcSEcCtD
Nalbuphine—Dyspepsia—Betamethasone—ulcerative colitis	0.000993	0.00128	CcSEcCtD
Nalbuphine—Dyspepsia—Dexamethasone—ulcerative colitis	0.000993	0.00128	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000991	0.00512	CbGpPWpGaD
Nalbuphine—Urticaria—Triamcinolone—ulcerative colitis	0.000987	0.00127	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000987	0.0051	CbGpPWpGaD
Nalbuphine—Urticaria—Methylprednisolone—ulcerative colitis	0.000985	0.00127	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000983	0.00508	CbGpPWpGaD
Nalbuphine—Body temperature increased—Triamcinolone—ulcerative colitis	0.000983	0.00126	CcSEcCtD
Nalbuphine—Oedema—Prednisone—ulcerative colitis	0.000982	0.00126	CcSEcCtD
Nalbuphine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.00098	0.00126	CcSEcCtD
Nalbuphine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000973	0.00125	CcSEcCtD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00097	0.00501	CbGpPWpGaD
Nalbuphine—Shock—Prednisone—ulcerative colitis	0.000966	0.00124	CcSEcCtD
Nalbuphine—Tachycardia—Prednisone—ulcerative colitis	0.000959	0.00123	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—ulcerative colitis	0.000949	0.00122	CcSEcCtD
Nalbuphine—Asthenia—Hydrocortisone—ulcerative colitis	0.000947	0.00122	CcSEcCtD
Nalbuphine—Pruritus—Hydrocortisone—ulcerative colitis	0.000934	0.0012	CcSEcCtD
Nalbuphine—Feeling abnormal—Betamethasone—ulcerative colitis	0.000929	0.0012	CcSEcCtD
Nalbuphine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000929	0.0012	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000922	0.00119	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000922	0.00119	CcSEcCtD
Nalbuphine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000916	0.00118	CcSEcCtD
Nalbuphine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000914	0.00118	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000908	0.00469	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000904	0.00467	CbGpPWpGaD
Nalbuphine—Urticaria—Betamethasone—ulcerative colitis	0.000896	0.00115	CcSEcCtD
Nalbuphine—Urticaria—Dexamethasone—ulcerative colitis	0.000896	0.00115	CcSEcCtD
Nalbuphine—Dizziness—Prednisolone—ulcerative colitis	0.000894	0.00115	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CCL20—ulcerative colitis	0.000893	0.00461	CbGpPWpGaD
Nalbuphine—Asthenia—Triamcinolone—ulcerative colitis	0.000892	0.00115	CcSEcCtD
Nalbuphine—Body temperature increased—Dexamethasone—ulcerative colitis	0.000892	0.00115	CcSEcCtD
Nalbuphine—Body temperature increased—Betamethasone—ulcerative colitis	0.000892	0.00115	CcSEcCtD
Nalbuphine—Abdominal pain—Dexamethasone—ulcerative colitis	0.000892	0.00115	CcSEcCtD
Nalbuphine—Abdominal pain—Betamethasone—ulcerative colitis	0.000892	0.00115	CcSEcCtD
Nalbuphine—Asthenia—Methylprednisolone—ulcerative colitis	0.00089	0.00114	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000884	0.00456	CbGpPWpGaD
Nalbuphine—Paraesthesia—Prednisone—ulcerative colitis	0.000882	0.00113	CcSEcCtD
Nalbuphine—Pruritus—Triamcinolone—ulcerative colitis	0.000879	0.00113	CcSEcCtD
Nalbuphine—Pruritus—Methylprednisolone—ulcerative colitis	0.000877	0.00113	CcSEcCtD
Nalbuphine—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000873	0.00451	CbGpPWpGaD
Nalbuphine—Dizziness—Hydrocortisone—ulcerative colitis	0.000873	0.00112	CcSEcCtD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000866	0.00447	CbGpPWpGaD
Nalbuphine—Dyspepsia—Prednisone—ulcerative colitis	0.000865	0.00111	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00086	0.00444	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000854	0.00441	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CCR6—ulcerative colitis	0.000854	0.00441	CbGpPWpGaD
Nalbuphine—Rash—Prednisolone—ulcerative colitis	0.000852	0.0011	CcSEcCtD
Nalbuphine—Dermatitis—Prednisolone—ulcerative colitis	0.000851	0.0011	CcSEcCtD
Nalbuphine—Headache—Prednisolone—ulcerative colitis	0.000847	0.00109	CcSEcCtD
Nalbuphine—Vomiting—Hydrocortisone—ulcerative colitis	0.000839	0.00108	CcSEcCtD
Nalbuphine—Rash—Hydrocortisone—ulcerative colitis	0.000832	0.00107	CcSEcCtD
Nalbuphine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000832	0.00107	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000831	0.00429	CbGpPWpGaD
Nalbuphine—Headache—Hydrocortisone—ulcerative colitis	0.000827	0.00106	CcSEcCtD
Nalbuphine—Dizziness—Triamcinolone—ulcerative colitis	0.000822	0.00106	CcSEcCtD
Nalbuphine—Dizziness—Methylprednisolone—ulcerative colitis	0.00082	0.00105	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisone—ulcerative colitis	0.000809	0.00104	CcSEcCtD
Nalbuphine—Asthenia—Betamethasone—ulcerative colitis	0.000809	0.00104	CcSEcCtD
Nalbuphine—Asthenia—Dexamethasone—ulcerative colitis	0.000809	0.00104	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000803	0.00103	CcSEcCtD
Nalbuphine—Nausea—Prednisolone—ulcerative colitis	0.000803	0.00103	CcSEcCtD
Nalbuphine—OPRD1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000799	0.00412	CbGpPWpGaD
Nalbuphine—Pruritus—Dexamethasone—ulcerative colitis	0.000798	0.00103	CcSEcCtD
Nalbuphine—Pruritus—Betamethasone—ulcerative colitis	0.000798	0.00103	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000796	0.00411	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000792	0.00409	CbGpPWpGaD
Nalbuphine—Vomiting—Triamcinolone—ulcerative colitis	0.00079	0.00102	CcSEcCtD
Nalbuphine—Vomiting—Methylprednisolone—ulcerative colitis	0.000789	0.00101	CcSEcCtD
Nalbuphine—Nausea—Hydrocortisone—ulcerative colitis	0.000784	0.00101	CcSEcCtD
Nalbuphine—Rash—Triamcinolone—ulcerative colitis	0.000784	0.00101	CcSEcCtD
Nalbuphine—Dermatitis—Triamcinolone—ulcerative colitis	0.000783	0.00101	CcSEcCtD
Nalbuphine—Rash—Methylprednisolone—ulcerative colitis	0.000782	0.00101	CcSEcCtD
Nalbuphine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000781	0.001	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—ulcerative colitis	0.00078	0.001	CcSEcCtD
Nalbuphine—Headache—Triamcinolone—ulcerative colitis	0.000779	0.001	CcSEcCtD
Nalbuphine—Headache—Methylprednisolone—ulcerative colitis	0.000777	0.000999	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—ulcerative colitis	0.000776	0.000999	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—ulcerative colitis	0.000776	0.000999	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—RELA—ulcerative colitis	0.00077	0.00398	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000766	0.00395	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL20—ulcerative colitis	0.000755	0.0039	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—CD4—ulcerative colitis	0.000754	0.00389	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000752	0.00388	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCR6—ulcerative colitis	0.000749	0.00387	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000748	0.00386	CbGpPWpGaD
Nalbuphine—Dizziness—Dexamethasone—ulcerative colitis	0.000746	0.000959	CcSEcCtD
Nalbuphine—Dizziness—Betamethasone—ulcerative colitis	0.000746	0.000959	CcSEcCtD
Nalbuphine—Nausea—Triamcinolone—ulcerative colitis	0.000738	0.00095	CcSEcCtD
Nalbuphine—Nausea—Methylprednisolone—ulcerative colitis	0.000737	0.000948	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000731	0.00378	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Prednisone—ulcerative colitis	0.000724	0.000931	CcSEcCtD
Nalbuphine—Vomiting—Dexamethasone—ulcerative colitis	0.000717	0.000922	CcSEcCtD
Nalbuphine—Vomiting—Betamethasone—ulcerative colitis	0.000717	0.000922	CcSEcCtD
Nalbuphine—Rash—Dexamethasone—ulcerative colitis	0.000711	0.000915	CcSEcCtD
Nalbuphine—Rash—Betamethasone—ulcerative colitis	0.000711	0.000915	CcSEcCtD
Nalbuphine—Dermatitis—Betamethasone—ulcerative colitis	0.00071	0.000914	CcSEcCtD
Nalbuphine—Dermatitis—Dexamethasone—ulcerative colitis	0.00071	0.000914	CcSEcCtD
Nalbuphine—Headache—Dexamethasone—ulcerative colitis	0.000707	0.000909	CcSEcCtD
Nalbuphine—Headache—Betamethasone—ulcerative colitis	0.000707	0.000909	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—ulcerative colitis	0.000705	0.000906	CcSEcCtD
Nalbuphine—OPRK1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.0007	0.00362	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL1B—ulcerative colitis	0.000696	0.0036	CbGpPWpGaD
Nalbuphine—Pruritus—Prednisone—ulcerative colitis	0.000695	0.000894	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—GHRL—ulcerative colitis	0.000688	0.00355	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000673	0.00348	CbGpPWpGaD
Nalbuphine—Nausea—Dexamethasone—ulcerative colitis	0.00067	0.000862	CcSEcCtD
Nalbuphine—Nausea—Betamethasone—ulcerative colitis	0.00067	0.000862	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00067	0.00346	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000659	0.0034	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000656	0.00339	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000656	0.00339	CbGpPWpGaD
Nalbuphine—Dizziness—Prednisone—ulcerative colitis	0.000649	0.000835	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—NFKB1—ulcerative colitis	0.000649	0.00335	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000647	0.00334	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCR6—ulcerative colitis	0.000633	0.00327	CbGpPWpGaD
Nalbuphine—Vomiting—Prednisone—ulcerative colitis	0.000624	0.000803	CcSEcCtD
Nalbuphine—Rash—Prednisone—ulcerative colitis	0.000619	0.000797	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—ulcerative colitis	0.000619	0.000796	CcSEcCtD
Nalbuphine—Headache—Prednisone—ulcerative colitis	0.000615	0.000791	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—GHRL—ulcerative colitis	0.000603	0.00312	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000596	0.00308	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000592	0.00306	CbGpPWpGaD
Nalbuphine—Nausea—Prednisone—ulcerative colitis	0.000583	0.00075	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000576	0.00297	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000575	0.00297	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—ADRB2—ulcerative colitis	0.00057	0.00294	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000557	0.00288	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000554	0.00286	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000541	0.0028	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—TGFB1—ulcerative colitis	0.000541	0.00279	CbGpPWpGaD
Nalbuphine—OPRD1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000539	0.00278	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL20—ulcerative colitis	0.000523	0.0027	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000522	0.0027	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000513	0.00265	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—GHRL—ulcerative colitis	0.00051	0.00263	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000505	0.00261	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000499	0.00258	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GNA12—ulcerative colitis	0.000492	0.00254	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000486	0.00251	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000482	0.00249	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000475	0.00245	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000472	0.00244	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000466	0.00241	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL20—ulcerative colitis	0.000458	0.00237	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000454	0.00235	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00045	0.00232	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000441	0.00228	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR6—ulcerative colitis	0.000438	0.00226	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GNA12—ulcerative colitis	0.000431	0.00223	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SEL1L—ulcerative colitis	0.000427	0.00221	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000427	0.0022	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000425	0.00219	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000423	0.00219	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000422	0.00218	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000409	0.00211	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL6—ulcerative colitis	0.000408	0.00211	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000401	0.00207	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000399	0.00206	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000398	0.00206	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000389	0.00201	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL20—ulcerative colitis	0.000387	0.002	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000386	0.00199	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR6—ulcerative colitis	0.000384	0.00198	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00038	0.00196	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SEL1L—ulcerative colitis	0.000375	0.00193	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000372	0.00192	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GNA12—ulcerative colitis	0.000364	0.00188	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000361	0.00187	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000358	0.00185	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GHRL—ulcerative colitis	0.000353	0.00182	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCR1—ulcerative colitis	0.000352	0.00182	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000345	0.00178	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CALM3—ulcerative colitis	0.000342	0.00177	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000341	0.00176	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000338	0.00175	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000337	0.00174	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR6—ulcerative colitis	0.000325	0.00168	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000322	0.00166	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000317	0.00164	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SEL1L—ulcerative colitis	0.000317	0.00164	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000315	0.00163	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GHRL—ulcerative colitis	0.00031	0.0016	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL20—ulcerative colitis	0.000309	0.0016	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCR1—ulcerative colitis	0.000308	0.00159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CALM3—ulcerative colitis	0.0003	0.00155	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000292	0.00151	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GNA12—ulcerative colitis	0.00029	0.0015	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000288	0.00149	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000286	0.00148	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000282	0.00146	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCR2—ulcerative colitis	0.000275	0.00142	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000275	0.00142	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000273	0.00141	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL20—ulcerative colitis	0.000271	0.0014	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000268	0.00138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GHRL—ulcerative colitis	0.000262	0.00135	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCR1—ulcerative colitis	0.000261	0.00135	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR6—ulcerative colitis	0.000259	0.00134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000256	0.00132	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	0.000255	0.00132	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	0.000253	0.00131	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000248	0.00128	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	0.000245	0.00127	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	0.000241	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000241	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00024	0.00124	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000239	0.00123	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	0.000229	0.00118	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	0.000228	0.00118	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	0.000227	0.00117	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000218	0.00112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000217	0.00112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	0.000215	0.00111	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	0.000215	0.00111	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	0.000209	0.00108	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	0.000204	0.00105	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000204	0.00105	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000202	0.00105	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	0.000202	0.00104	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	0.0002	0.00103	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	0.000199	0.00103	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	0.000192	0.000991	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000184	0.00095	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	0.000183	0.000945	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	0.000182	0.000939	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	0.000177	0.000915	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	0.000175	0.000901	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	0.000173	0.000892	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	0.00017	0.00088	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	0.000169	0.000872	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000155	0.000803	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	0.000155	0.000799	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	0.000155	0.000799	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	0.000151	0.000782	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	0.00015	0.000773	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000149	0.000772	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	0.000149	0.000767	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	0.000147	0.000762	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	0.000147	0.000757	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000141	0.000729	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000136	0.000704	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	0.000136	0.000701	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	0.000135	0.000697	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	0.00013	0.000673	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	0.000129	0.000664	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	0.000128	0.000661	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000126	0.000652	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000124	0.000639	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	0.000118	0.000611	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000115	0.000595	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	0.000115	0.000592	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	0.00011	0.000569	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	0.000109	0.000561	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000105	0.00054	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	0.0001	0.000516	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	9.14e-05	0.000472	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RELA—ulcerative colitis	8.85e-05	0.000457	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	8.34e-05	0.000431	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	8.01e-05	0.000414	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—ulcerative colitis	7.97e-05	0.000412	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	7.93e-05	0.00041	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RELA—ulcerative colitis	7.76e-05	0.000401	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	7.54e-05	0.00039	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	7.46e-05	0.000386	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	7.31e-05	0.000378	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—ulcerative colitis	6.99e-05	0.000361	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	6.95e-05	0.000359	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	6.77e-05	0.00035	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	6.71e-05	0.000346	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	6.61e-05	0.000342	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RELA—ulcerative colitis	6.56e-05	0.000339	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	6.54e-05	0.000338	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	6.22e-05	0.000321	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	6.18e-05	0.000319	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—ulcerative colitis	5.91e-05	0.000305	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	5.88e-05	0.000304	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	5.88e-05	0.000304	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	5.59e-05	0.000289	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	5.53e-05	0.000286	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	5.45e-05	0.000282	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—ulcerative colitis	5.12e-05	0.000264	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	4.97e-05	0.000257	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—ulcerative colitis	4.69e-05	0.000242	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	4.61e-05	0.000238	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—ulcerative colitis	4.49e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—ulcerative colitis	4.11e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—ulcerative colitis	3.79e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—ulcerative colitis	3.47e-05	0.000179	CbGpPWpGaD
